These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33983584)

  • 1. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
    Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
    Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
    Kim S; Shin D; Min A; Kim M; Na D; Lee HB; Ryu HS; Yang Y; Woo GU; Lee KH; Lee DW; Kim TY; Lee C; Im SA; Kim JI
    J Transl Med; 2021 Jan; 19(1):7. PubMed ID: 33407601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
    Gómez-Miragaya J; Morán S; Calleja-Cervantes ME; Collado-Sole A; Paré L; Gómez A; Serra V; Dobrolecki LE; Lewis MT; Diaz-Lagares A; Eroles P; Prat A; Esteller M; González-Suárez E
    Mol Cancer Res; 2019 Oct; 17(10):2063-2076. PubMed ID: 31320385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
    Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
    Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
    Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
    Lan T; Xue X; Dunmall LC; Miao J; Wang Y
    Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenograft model in colorectal cancer basic and translational research.
    Liu X; Xin Z; Wang K
    Animal Model Exp Med; 2023 Feb; 6(1):26-40. PubMed ID: 36543756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Bladder Cancer Xenografts.
    Bernardo C; Santos LL
    Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
    Hamada A
    Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
    Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
    Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis.
    Ma D; Hernandez GA; Lefebvre AEYT; Alshetaiwi H; Blake K; Dave KR; Rauf M; Williams JW; Davis RT; Evans KT; Longworth A; Masoud MYG; Lee R; Edwards RA; Digman MA; Kessenbrock K; Lawson DA
    Commun Biol; 2021 Nov; 4(1):1268. PubMed ID: 34741115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Derived Xenograft Models for Ovarian Cancer.
    Tran TM; Ho GY; Chu S
    Methods Mol Biol; 2024; 2806():187-196. PubMed ID: 38676803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.
    Mercatali L; La Manna F; Groenewoud A; Casadei R; Recine F; Miserocchi G; Pieri F; Liverani C; Bongiovanni A; Spadazzi C; de Vita A; van der Pluijm G; Giorgini A; Biagini R; Amadori D; Ibrahim T; Snaar-Jagalska E
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
    Eckhardt BL; Gagliardi M; Iles L; Evans K; Ivan C; Liu X; Liu CG; Souza G; Rao A; Meric-Bernstam F; Ueno NT; Bartholomeusz GA
    PLoS One; 2018; 13(5):e0195932. PubMed ID: 29768500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.